RRREX
Price
$23.91
Change
-$0.04 (-0.17%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

RRREX vs VGSNX

Header iconRRREX vs VGSNX Comparison
Open Charts RRREX vs VGSNXBanner chart's image
DWS RREEF Real Estate Securities S
Price$23.91
Change-$0.04 (-0.17%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RRREX vs VGSNX Comparison Chart
Loading...
VS
RRREX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRREX is a Buy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. RRREX (1.23B). VGSNX pays higher dividends than RRREX: VGSNX (4.01) vs RRREX (2.00). RRREX was incepted earlier than VGSNX: RRREX (19 years) vs VGSNX (21 years). RRREX is a more actively managed with annual turnover of: 84.00 vs. VGSNX (9.00). RRREX has a lower initial minimum investment than VGSNX: RRREX (2500) vs VGSNX (5000000). VGSNX (26.90) and RRREX (26.60) have marching annual gain over last year. VGSNX return over 5 years is better than : 26.84 vs. RRREX (8.64).
RRREXVGSNXRRREX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years21 years-
Gain YTD14.70813.452109%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B70.5B2%
Annual Yield % from dividends2.004.0150%
Returns for 1 year26.6026.9099%
Returns for 3 years-3.843.64-105%
Returns for 5 years8.6426.8432%
Returns for 10 years30.1887.2935%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics